Hermann Eibel
Impact in
- Immunology top 0.5%
- Immunodeficiency and Autoimmune Disorders
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Hematology top 2%
Papers in
- Immunology 71
- Immunodeficiency and Autoimmune Disorders 41
- T-cell and B-cell Immunology 36
- Immune Cell Function and Interaction 33
- Immunotherapy and Immune Responses 7
- Co-authors
- Klaus Warnatz (26 shared papers)Bodo Grimbacher (17 shared papers)Michael Schlesier (16 shared papers)Cristian R. Smulski (8 shared papers)Kathrin Pieper (4 shared papers)Hans Peter (10 shared papers)Ruth Dräger (5 shared papers)Peter Philippsen (3 shared papers)
- Journals
- The Journal of Immunology (11 papers)Clinical Immunology (7 papers)European Journal of Immunology (6 papers)Blood (5 papers)Journal of Allergy and Clinical Immunology (5 papers)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Hermann Eibel
99 papers receiving 5.4k citations
Hermann Eibel's Hit Papers
Peers
Comparison fields: 5 of 106
- Immunology 3.5k
- Hematology 482
- Genetics 411
- Genetics 912
- Rheumatology 391
Countries citing papers authored by Hermann Eibel
This map shows the geographic impact of Hermann Eibel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hermann Eibel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hermann Eibel more than expected).
Fields of papers citing papers by Hermann Eibel
This network shows the impact of papers produced by Hermann Eibel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hermann Eibel. The network helps show where Hermann Eibel may publish in the future.
Co-authors
The 25 scholars most cited alongside Hermann Eibel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 100 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency Hit paper breakdown → | 2003 | 535 |
| 2 | 2002 | 488 | |
| 3 | 2013 | 371 | |
| 4 | 2009 | 263 | |
| 5 | 2009 | 263 | |
| 6 | 2018 | 259 | |
| 7 | 2004 | 228 | |
| 8 | 1996 | 188 | |
| 9 | 2011 | 138 | |
| 10 | 2013 | 124 | |
| 11 | 2002 | 117 | |
| 12 | 1984 | 98 | |
| 13 | 2002 | 95 | |
| 14 | 1999 | 92 | |
| 15 | 2014 | 91 | |
| 16 | 1994 | 77 | |
| 17 | 2007 | 73 | |
| 18 | 1998 | 71 | |
| 19 | 2011 | 68 | |
| 20 | 1994 | 68 |
About Hermann Eibel
Hermann Eibel is a scholar working on Immunology, Molecular Biology, Oncology, Rheumatology and Genetics, having authored 100 papers that have together received 5.5k indexed citations. Recurring topics across this work include Immunodeficiency and Autoimmune Disorders (41 papers), T-cell and B-cell Immunology (36 papers), Immune Cell Function and Interaction (33 papers), Rheumatoid Arthritis Research and Therapies (10 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Blood disorders and treatments (8 papers), NF-κB Signaling Pathways (8 papers) and Immunotherapy and Immune Responses (7 papers). The work is most often cited by research in Immunology (3.5k citations), Hematology (482 citations), Genetics (411 citations), Genetics (912 citations) and Rheumatology (391 citations). Hermann Eibel has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Klaus Warnatz, Bodo Grimbacher, Michael Schlesier, Cristian R. Smulski, Kathrin Pieper, Hans Peter, Ruth Dräger, Peter Philippsen, Hans‐Hartmut Peter and Marta Rizzi. Their work appears in journals such as The Journal of Immunology, Clinical Immunology, European Journal of Immunology, Blood and Journal of Allergy and Clinical Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.